Search

Meet MIMARK Diagnostics, S.L., our new member. We talked to Marina Rigau, CEO and founder of the company.

Some cancer therapies can affect the skin, making extra protection from the sun necessary during and after cancer treatment

BIOLAN renews the Performance Tested Method PTM AOAC 051604 certificate for the quantification of histamine concentration with the new BIOFISH 3000 HIS biosensor model

SphereFlash®, IUL’s automatic colony counter, is the answer for laboratories that want to automate their colony count proces

Specipig has opened a neonatal intensive care unit (NICU) at its research facilities in the Barcelona area

BCN HEALTH has published the study ‘Estimating the cost of thalassaemia care across the world: A Thalassaemia International Federation model’ in the journal ‘Hemoglobin’

MSD ha publicado su informe de 2021/2022 de avances en materia medioambiental, social y de gobernanza

La Inteligencia Artificial está cambiando el mundo en el que vivimos y se encuentra presente en casi todos los sectores, la Propiedad Intelectual no es una excepción

ADNTRO has been awarded as one of Europe's Top 10 Genomic Solutions providers in 2022, for standing out with its comprehensive domain expertise DNA studies and research focused on delivering consumer

Meet PALMEERA, our new partner. We talked to Jorge González Cánovas, the company's Operations Director.

The VI edition of the SME of the year awards was held in Bilbao on 18 July. These awards recognise essential aspects of the contribution to society and the economy of SMEs, which make up 99.8% of the

ALGAVILLAGE, proyecto conjunto de la compañía británica Firglas y la biotecnológica almeriense Biorizon Biotech, avanza firme con la construcción de su planta de microalgas en Carboneras (Almería)

Oryzon invests $8.1 million in R&D in the first half 2022

To explore Oryzon’s HDAC6 inhibitors on Charcot-Marie-Tooth disease CMTRF to provide funding for in vivo efficacy tests in CMT preclinical model

GENESIS Biomed will be the managing entity of the vehicle

This new launch follows a trend of expansion of the Spanish brand after its success in Europe and the Americas, with a significant presence in countries such as Mexico, Colombia and Argentina. Today

PVPHARM, a leading company in specialized pharmacovigilance and clinical safety services, has a group of experts that can manage CTIS on behalf of any clinical trial sponsor, and related tasks

The company plans to continue pushing forward the development of in silico enzyme discovery and design projects in the United States, especially in the area of the Life Sciences

Oryzon and NCI will collaborate to assess the safety and efficacy of iadademstat in oncology patients with different hematological and solid tumors

Almirall recently announced topline results from one-year analyses of the efficacy and safety of lebrikizumab, an investigational IL-13 inhibitor for the treatment of patients with moderate-to-severe

The event made public the winning projects that put the patient at the centre of the healthcare system unveiled